ZoomRx is a company based in the United States, established in 2009, that operates within the Business Services industry, specifically focusing on Advertising and Marketing, Management Consulting, and Corporate Services. With a workforce of 501 to 1,000 employees, the company has reported revenue of approximately $83 million. ZoomRx engages in research and analysis related to artificial intelligence (AI) applications in the life sciences sector, as evidenced by their publication, "FERMA State of AI Report" from April 2024. This report highlights insights from over 200 life sciences professionals regarding the use of AI in pharmaceuticals, including its role in enhancing drug interaction simulations, developing personalized treatment plans, and managing medical literature for decision-making support. The report also discusses the prevalence of AI adoption and associated concerns, particularly around data security and the use of tools like ChatGPT within life sciences companies. Overall, ZoomRx's expertise appears to center on integrating AI technology into healthcare and pharmaceutical practices, focusing on improving efficiency and decision-making processes.